These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 11389037)
1. Mitochondria-targeting drugs arsenic trioxide and lonidamine bypass the resistance of TPA-differentiated leukemic cells to apoptosis. Sordet O; Rébé C; Leroy I; Bruey JM; Garrido C; Miguet C; Lizard G; Plenchette S; Corcos L; Solary E Blood; 2001 Jun; 97(12):3931-40. PubMed ID: 11389037 [TBL] [Abstract][Full Text] [Related]
2. Selective inhibition of apoptosis by TPA-induced differentiation of U937 leukemic cells. Sordet O; Bettaieb A; Bruey JM; Eymin B; Droin N; Ivarsson M; Garrido C; Solary E Cell Death Differ; 1999 Apr; 6(4):351-61. PubMed ID: 10381626 [TBL] [Abstract][Full Text] [Related]
3. Curcumin stimulates reactive oxygen species production and potentiates apoptosis induction by the antitumor drugs arsenic trioxide and lonidamine in human myeloid leukemia cell lines. Sánchez Y; Simón GP; Calviño E; de Blas E; Aller P J Pharmacol Exp Ther; 2010 Oct; 335(1):114-23. PubMed ID: 20605902 [TBL] [Abstract][Full Text] [Related]
4. Arsenic trioxide sensitizes promonocytic leukemia cells to TNFalpha-induced apoptosis via p38-MAPK-regulated activation of both receptor-mediated and mitochondrial pathways. Amrán D; Sánchez Y; Fernández C; Ramos AM; de Blas E; Bréard J; Calle C; Aller P Biochim Biophys Acta; 2007 Nov; 1773(11):1653-63. PubMed ID: 17673311 [TBL] [Abstract][Full Text] [Related]
5. 12-O-tetradecanoylphorbol-13-acetate may both potentiate and decrease the generation of apoptosis by the antileukemic agent arsenic trioxide in human promonocytic cells. Regulation by extracellular signal-regulated protein kinases and glutathione. Fernández C; Ramos AM; Sancho P; Amrán D; de Blas E; Aller P J Biol Chem; 2004 Jan; 279(5):3877-84. PubMed ID: 14610070 [TBL] [Abstract][Full Text] [Related]
6. Arsenic trioxide induces apoptosis of human monocytes during macrophagic differentiation through nuclear factor-kappaB-related survival pathway down-regulation. Lemarie A; Morzadec C; Mérino D; Micheau O; Fardel O; Vernhet L J Pharmacol Exp Ther; 2006 Jan; 316(1):304-14. PubMed ID: 16174796 [TBL] [Abstract][Full Text] [Related]
7. Increased apoptotic efficacy of lonidamine plus arsenic trioxide combination in human leukemia cells. Reactive oxygen species generation and defensive protein kinase (MEK/ERK, Akt/mTOR) modulation. Calviño E; Estañ MC; Simón GP; Sancho P; Boyano-Adánez Mdel C; de Blas E; Bréard J; Aller P Biochem Pharmacol; 2011 Dec; 82(11):1619-29. PubMed ID: 21889928 [TBL] [Abstract][Full Text] [Related]
8. Arsenic induces apoptosis of multidrug-resistant human myeloid leukemia cells that express Bcr-Abl or overexpress MDR, MRP, Bcl-2, or Bcl-x(L). Perkins C; Kim CN; Fang G; Bhalla KN Blood; 2000 Feb; 95(3):1014-22. PubMed ID: 10648417 [TBL] [Abstract][Full Text] [Related]
9. Arsenic trioxide selectively induces acute promyelocytic leukemia cell apoptosis via a hydrogen peroxide-dependent pathway. Jing Y; Dai J; Chalmers-Redman RM; Tatton WG; Waxman S Blood; 1999 Sep; 94(6):2102-11. PubMed ID: 10477740 [TBL] [Abstract][Full Text] [Related]
10. Arsenic trioxide-induced apoptosis and differentiation are associated respectively with mitochondrial transmembrane potential collapse and retinoic acid signaling pathways in acute promyelocytic leukemia. Cai X; Shen YL; Zhu Q; Jia PM; Yu Y; Zhou L; Huang Y; Zhang JW; Xiong SM; Chen SJ; Wang ZY; Chen Z; Chen GQ Leukemia; 2000 Feb; 14(2):262-70. PubMed ID: 10673743 [TBL] [Abstract][Full Text] [Related]
12. Arsenic trioxide induces apoptosis in human T-cell leukemia virus type 1- and type 2-infected cells by a caspase-3-dependent mechanism involving Bcl-2 cleavage. Mahieux R; Pise-Masison C; Gessain A; Brady JN; Olivier R; Perret E; Misteli T; Nicot C Blood; 2001 Dec; 98(13):3762-9. PubMed ID: 11739184 [TBL] [Abstract][Full Text] [Related]
13. Arsenic trioxide induces apoptosis of myeloid leukemia cells by activation of caspases. Huang XJ; Wiernik PH; Klein RS; Gallagher RE Med Oncol; 1999 Apr; 16(1):58-64. PubMed ID: 10382944 [TBL] [Abstract][Full Text] [Related]
14. Combination treatment with arsenic trioxide and phytosphingosine enhances apoptotic cell death in arsenic trioxide-resistant cancer cells. Park MT; Kang YH; Park IC; Kim CH; Lee YS; Chung HY; Lee SJ Mol Cancer Ther; 2007 Jan; 6(1):82-92. PubMed ID: 17237268 [TBL] [Abstract][Full Text] [Related]
15. Apoptosis induced by arsenic trioxide in leukemia U937 cells is dependent on activation of p38, inactivation of ERK and the Ca2+-dependent production of superoxide. Iwama K; Nakajo S; Aiuchi T; Nakaya K Int J Cancer; 2001 May; 92(4):518-26. PubMed ID: 11304686 [TBL] [Abstract][Full Text] [Related]
16. Arsenic trioxide induces apoptosis in peripheral blood T lymphocyte subsets by inducing oxidative stress: a role of Bcl-2. Gupta S; Yel L; Kim D; Kim C; Chiplunkar S; Gollapudi S Mol Cancer Ther; 2003 Aug; 2(8):711-9. PubMed ID: 12939460 [TBL] [Abstract][Full Text] [Related]
17. Pharmacologic inhibitors of PI3K/Akt potentiate the apoptotic action of the antileukemic drug arsenic trioxide via glutathione depletion and increased peroxide accumulation in myeloid leukemia cells. Ramos AM; Fernández C; Amrán D; Sancho P; de Blas E; Aller P Blood; 2005 May; 105(10):4013-20. PubMed ID: 15665116 [TBL] [Abstract][Full Text] [Related]
18. Arsenic trioxide-induced apoptosis in U937 cells involve generation of reactive oxygen species and inhibition of Akt. Choi YJ; Park JW; Suh SI; Mun KC; Bae JH; Song DK; Kim SP; Kwon TK Int J Oncol; 2002 Sep; 21(3):603-10. PubMed ID: 12168106 [TBL] [Abstract][Full Text] [Related]
19. Arsenic trioxide-induced death of neuroblastoma cells involves activation of Bax and does not require p53. Karlsson J; Øra I; Pörn-Ares I; Påhlman S Clin Cancer Res; 2004 May; 10(9):3179-88. PubMed ID: 15131059 [TBL] [Abstract][Full Text] [Related]
20. The role of mitochondrial targeting in arsenic trioxide-induced apoptosis in myeloid cell lines. Körper S; Nolte F; Thiel E; Schrezenmeier H; Rojewski MT Br J Haematol; 2004 Jan; 124(2):186-9. PubMed ID: 14687028 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]